Teleflex PE ratio TFX
Share price divided by earnings per share over the last twelve months, since 2011.
- Today, Oct 23, 2026
- n/m
- losses over the last year
- Last meaningful
- 29.3×
- Oct 2025
- 10-year median
- 38.2×
- 10-year range
- 18.1× to 197×
- Peer median
- 36.9×
Teleflex has no meaningful PE ratio today: it lost $23.29 a share over the last twelve months, and a PE needs earnings.
It was last meaningful in Oct 2025, at 29.3×.
On the days it had one over the last ten years, its median was 38.2×, from 18.1× in Oct 2022 to 197× in Feb 2019.
PE ratio over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2025 | 29.3× | 27.3× | 99.7× |
| 2024 | 35.7× | 27.4× | 44.3× |
| 2023 | 29.2× | 23.0× | 35.5× |
| 2022 | 28.6× | 18.1× | 37.5× |
| 2021 | 35.9× | 33.3× | 71.8× |
| 2020 | 53.0× | 24.9× | 53.0× |
| 2019 | 39.5× | 35.2× | 197× |
| 2018 | 176× | 46.1× | 190× |
| 2017 | 45.4× | 28.6× | 48.9× |
| 2016 | 27.8× | 24.6× | 34.3× |
| 2015 | 32.4× | 29.4× | 34.5× |
| 2014 | 31.3× | 27.4× | 31.9× |
| 2013 | 27.8× | 26.2× | 30.6× |
| 2012 | 8.0× | 7.4× | 10.8× |
| 2011 | 10.5× | 9.4× | 11.3× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Teleflex's size, closest first, today.
| Company | PE ratio |
|---|---|
| TFXTeleflex | n/m |
| MMSIMerit Medical Systems | 38.6× |
| HAEHaemonetics | 58.1× |
| MSAMSA Safety | 22.7× |
| VNTVontier | 14.3× |
| BMIBadger Meter | 35.3× |
| ICUIICU Medical | 141× |
| NVSTEnvista | 40.7× |
| PODDInsulet | 27.9× |
| WRBYWarby Parker | 370× |
| GMEDGlobus Medical | 20.8× |
| Peer median | 36.9× |
What the PE ratio tells you
Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.
Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.
More on Teleflex
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.